Cyclosporine 0.1% Eye Drops as Prophylactic Treatment In Cataract Surgery

Inclusion Criteria: * \>18 years old * Postmenopausal women for whom cataract surgery has been scheduled * Stage N2-3; C1-2 according (Lens Opacities classification System) LOCS * Willing to sign informed consent and fully participate to all length of the study * Patients without any previous medical history of ocular and/or systemic inflammatory, autoimmune or auto inflammatory disease * Patient with no history of ocular surgery * Patients without any previous or concomitant ocular diseases Exclusion Criteria: * Patients under topical or systemic anti- inflammatory drugs Patients with a concomitant diagnosis of glaucoma, or on therapy with antiglaucoma drugs * Patients on systemic or local therapy with drugs that alter the secretion of the tear film (beta blockers, antidepressants and psychotropics) * Patients with a history of allergic, congenital, autoimmune systemic diseases * Patients who have undergone previous eye surgery * Ocular or peri-ocular malignancies or premalignant conditions * Active or suspected ocular or peri-ocular infection. * Complicated Cataract Surgery * Patients with a positive pregnancy testAllergy or reaction history to study drug * Patients who participated in a clinical trial in which an investigational drug was administered within 30 days or 5 half-lives of the study drug